2022. Lipid profile in people starting antiretroviral therapy with efavirenz or dolutegravir based regimens from a reference center in Brazil: a cohort study. Research, Society and Development. 11, 5 (Apr. 2022), e55811528662. DOI:https://doi.org/10.33448/rsd-v11i5.28662.